Dermapharm Holding SE
DUS:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
DUS:DMP
Watchlist
Price: 38.25 EUR 2.27%
Market Cap: 4.1B EUR

Intrinsic Value

The intrinsic value of one DMP stock under the Base Case scenario is 50.45 EUR. Compared to the current market price of 38.25 EUR, Dermapharm Holding SE is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DMP Intrinsic Value
50.45 EUR
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dermapharm Holding SE

What is Valuation History?
Ask AI Assistant
What other research platforms think about DMP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DMP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dermapharm Holding SE.

Explain Valuation
Compare DMP to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DMP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dermapharm Holding SE

Current Assets 643.4m
Cash & Short-Term Investments 149.9m
Receivables 131.1m
Other Current Assets 362.4m
Non-Current Assets 1.5B
Long-Term Investments 95.5m
PP&E 312.8m
Intangibles 1.1B
Other Non-Current Assets -1k
Current Liabilities 292.6m
Accounts Payable 93.8m
Other Current Liabilities 198.7m
Non-Current Liabilities 1.2B
Long-Term Debt 933.4m
Other Non-Current Liabilities 241.8m
Efficiency

Free Cash Flow Analysis
Dermapharm Holding SE

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dermapharm Holding SE

Revenue
1.2B EUR
Cost of Revenue
-387.8m EUR
Gross Profit
772.3m EUR
Operating Expenses
-555.3m EUR
Operating Income
217m EUR
Other Expenses
-101m EUR
Net Income
116m EUR
Fundamental Scores

DMP Profitability Score
Profitability Due Diligence

Dermapharm Holding SE's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive ROE
51/100
Profitability
Score

Dermapharm Holding SE's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

DMP Solvency Score
Solvency Due Diligence

Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Average Altman Z-Score
38/100
Solvency
Score

Dermapharm Holding SE's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DMP Price Targets Summary
Dermapharm Holding SE

Wall Street analysts forecast DMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMP is 42.61 EUR with a low forecast of 34.16 EUR and a high forecast of 50.13 EUR.

Lowest
Price Target
34.16 EUR
11% Downside
Average
Price Target
42.61 EUR
11% Upside
Highest
Price Target
50.13 EUR
31% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one DMP stock?

The intrinsic value of one DMP stock under the Base Case scenario is 50.45 EUR.

Is DMP stock undervalued or overvalued?

Compared to the current market price of 38.25 EUR, Dermapharm Holding SE is Undervalued by 24%.

Back to Top